Solid Tumor Cancer Treatment Market Will Generate Record Revenue by 2029

The global solid tumor cancer treatment market is anticipated to grow at a CAGR of 12.5% during the forecast period. Product innovations have emerged as a key trend gaining popularity in the solid tumor cancer treatment market. Major companies operating in the market are focusing on innovating new products and treatments to sustain their position in the market. For instance, in March 2022, Shanghai Henlius Biotech, a China-based biopharmaceutical company, launched the PD-1 inhibitor HANSIZHUANG, its first innovative monoclonal antibody. It was developed for the treatment of adults with advanced unresectable or metastatic MSI-H (microsatellite instability-high) solid tumors that have not responded to prior conventional treatments. The approval of HANSIZHUANG gives patients with MSI-H solid tumors fresh hope and better matches the demand for clinical treatment and tumor medicine. It also fosters the high-quality development of China's biopharmaceutical industry and empowers domestic precision immunotherapy for cancer.

The growing drug approvals for solid tumor cancer treatment will further boost market growth. For instance, in December 2022, SQZ Biotechnology Company announced that the U.S. Food and Drug Administration has granted Fast Track Designation for its Enhanced Antigen Presenting Cells (eAPC) therapeutic candidate for the treatment of solid metastatic tumors. In November 2022, a leading clinical-stage biotechnology company announced that the U.S. Food and Drug Administration had approved the company's investigational drug application. The study will evaluate VISTA-blocking immunotherapy as a potential treatment for patients with advanced solid tumors. In September 2022, Eli Lilly and Company received the U.S. Food and Drug Administration approval for Retevmo (selpercatinib capsules) for adult patients with locally advanced or metastatic solid tumors. 

To Request a Sample of our Report on Solid Tumor Cancer Treatment Market:  https://www.omrglobal.com/request-sample/solid-tumor-cancer-treatment-market

Market Coverage

•                 The market number available for – 2022-2030

•                 Base year- 2022

•                 Forecast period- 2023-2030

Segment Covered- 

·                  Type

·                  Drug Type

·                  Therapy

·                  End-User

Regions Covered-

•                 North America

•                 Europe

•                 Asia-Pacific

•                 Rest of the World

•                 Competitive Landscape- including Amgen Inc., AstraZeneca, Eli Lilly, and Co., F. Hoffman-La Roche Ltd, and others.

A full Report of Solid Tumor Cancer Treatment Market is Available @  https://www.omrglobal.com/industry-reports/solid-tumor-cancer-treatment-market

Solid Tumor Cancer Treatment Market Report Segment

By Type

·                  Breast Cancer

·                  Lung Cancer

·                  Colorectal Cancer

·                  Prostate Cancer

·                  Cervical Cancer

By Drug Type

·                  Carboplatin

·                  Cisplatin

·                  Gemcitabine

·                  Paclitaxel

·                  Doxorubicin

·                  Bevacizumab

·                  Erlotinib

·                  Sunitinib

·                  Everolimusa

By Therapy

·                  Chemotherapy

·                  Targeted Therapy

·                  Immunotherapy

·                  Hormone Therapy

·                  Surgical Procedures

By End-User

·                  Hospitals

·                  Specialty Clinics

·                  Research Institutes

·                  Homecare

Solid Tumor Cancer Treatment Market Report Segment by Region

North America                                                                                                           

·        United States

·        Canada                     

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan              

·                  South Korea

·                  Rest of APAC

Rest of the World

•       Latin America

•       Middle East and Africa 

Company Profiles 

·                  Allergan

·                  B. Braun Melsungen AG

·                  Bayer AG

·                  Boehringer Ingelheim International GmbH

·                  Bristol Myers Squibb & Company

·                  Celgene Corp

·                  Celldex Therapeutics Inc.

·                  Dr. Reddy’s Laboratories Ltd.

·                  Gilead Sciences, Inc.

·                  GlaxoSmithKline PLC

·                  Hikma Pharmaceuticals PLC

·                  Lupin

·                  Merck & Co. Inc.

·                  Novartis AG

·                  Olympus Medical Systems

·                  Pfizer Inc

·                  Takeda Pharmaceutical Company Ltd.

·                  Teva Pharmaceutical Industries Ltd.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/solid-tumor-cancer-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more